Quantum BioPharma Invites Shareholders To The $700M+ Court Case The Company Has Filed Against CIBC, RBC, And Others For Alleged Spoofing/Stock Price Manipulation
Quantum BioPharma Invites Shareholders To The $700M+ Court Case The Company Has Filed Against CIBC, RBC, And Others For Alleged Spoofing/Stock Price Manipulation
Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE) is pleased to follow up on recent events concerning the complaint filed by the Company in the United States courts, that alleges that CIBC World Markets, RBC Dominion Securities and others (the "Defendants") engaged in market manipulation in the share price of the Company. The Company, as well as its shareholders, have suffered financial and emotional losses resulting from this alleged manipulation. We are determined to right this wrong by the Defendants and reverse the Company losses and claim punitive damages to the extent determined by the courts. As a result, prominent legal teams have been assembled to pursue the recovery of all losses and damages impacting our Company. The law firms have agreed to be compensated without cost to the Company but solely on a contingency basis, meaning that the Company will not be billed for legal costs in this matter. The Company itself is seeking damages of more than US$700M we believe it has suffered. The shareholders can find updated information about the case on the Quantum vs Banks page of our website which will be updated periodically.
Quantum BioPharma Ltd. (納斯達克:QNTM)(cse:QNTM)(FRA:0K91) ("公司")原名fsd pharma公司 (納斯達克:HUGE)(cse:HUGE),很高興對最近發生的有關公司在美國法院提起的投訴一事進行跟進,指控加拿大帝國商業銀行世界市場、RBC Dominion Securities等人("被告")操縱了公司股價。公司及其股東因這種所稱的操縱而遭受了財務和情感損失。我們決心由被告糾正此錯誤,並通過法院裁定的程度來扭轉公司損失並主張懲罰性賠償。因此,我們已經組建了備受矚目的法律團隊來追求所有損失和損害對我們公司的影響的補償。各律所同意不對公司收取費用,而完全基於結果,這意味着公司在此事中不會被要求支付法律成本。公司本身正在尋求逾70000萬美元的賠償,我們相信公司已經遭受了損失。股東可以在我們網站的Quantum vs 銀行頁面找到關於此案的更新信息,該頁面將定期更新。
Quantum Biopharma previously know as FSD Pharma and traded under the symbol HUGE is inviting and requesting shareholders to join with the company in its quest to get justice for itself and all affected shareholders, both past and current. The company strongly believes the more affected and harmed shareholders that come forward to share specific details of their losses, the stronger the case will become against the alleged perpetrators, for the vast financial harm they have caused.
量子生物製藥,之前稱爲fsd pharma,並以標的HUGE進行交易,邀請並請求股東與公司共同努力,爲公司及所有受影響的股東(包括過去和現在的股東)爭取正義。公司堅信,越多的受害和受損的股東站出來分享其損失的具體細節,對被控訴的施害者的案件就會變得越強有力,因爲他們造成了巨大的財務傷害。
譯文內容由第三人軟體翻譯。